Sameer Goregaoker

Sameer Goregaoker joined Coherus in December 2024 and is currently Chief Commercial Officer, responsible for leading Commercial functions including Marketing, Sales, Market Access, and Commercial Operations.

Sameer brings over 20 years of biopharmaceutical commercialization and research experience to Coherus, with a strong focus in Oncology. Prior to joining Coherus, Sameer served as Vice President, Head of Marketing and Launch Readiness at Crinetics Pharmaceuticals where he led a cross-functional team in preparing for the company’s first commercial launch. Sameer previously worked for 4 years at Ipsen North America as Vice President, Oncology Marketing. At Ipsen, Sameer held multiple commercial responsibilities including solid tumors and hematology P&L leadership, lifecycle planning, launch readiness, and integration of commercial organizations post-acquisition. Prior to Ipsen, Sameer spent fourteen years at Amgen in various leadership roles, including Hematology Brand leader, Sales Leader branded Oncology and biosimilars, Head of Oncology Digital and Patient Innovation, and contributed to the commercialization of multiple Oncology brands. In addition to Oncology, Sameer’s commercial experience spans across Nephrology, Rheumatology, Dermatology, Endocrinology and Rare Diseases. Prior to transitioning to biopharmaceutical commercialization, Sameer worked as a research scientist at Schering Plough focusing on Gene Therapy applications for Chronic Pain.

Sameer holds an MBA from Cornell University and a PhD in Molecular and Cell Biology from the University of Maryland at College Park.